The under-expression of CD81, CD79b, and positive CD43 and ROR1 expression, noted in the DURAClone CLB panel specifically assists in distinguishing B-cell CLL from mantle cell lymphoma and other CD5 negative B-cell LPDs. Here, CD5 is linked to B-cell chronic lymphocytic leukemia.